Do you think STEM will have NVIV to contend with? If not, why not? Recall that NVIV contemplates use of cellular technology in connection/combination with its own spinal scaffold already utilized with 2 patients, with 4 more now contemplated.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.